Skip to main content
Get facts, not fiction
Get Started
SubscribeLogin
Published • loading... • Updated

Iovance Biotherapeutics (NASDAQ:IOVA) Stock Gets Price Target Increase from Robert W. Baird

Summary by MarketBeat
Robert W. Baird raised their target price on shares of Iovance Biotherapeutics from $6.00 to $11.00 and gave the company a "neutral" rating in a report on Thursday.

1 Articles

MarketBeatMarketBeat
Center

Iovance Biotherapeutics (NASDAQ:IOVA) Stock Gets Price Target Increase from Robert W. Baird

Robert W. Baird raised their target price on shares of Iovance Biotherapeutics from $6.00 to $11.00 and gave the company a "neutral" rating in a report on Thursday.

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Thursday, October 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

San Carlos icon

San Carlos

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal